Cyproheptadine
Cyproheptadine is an antihistamine used to relieve allergic rhinitis, allergic skin reactions, cold urticaria, and related allergic conditions.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 36 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Cyproheptadine: Patient Information Guide
A plain-language walkthrough of Cyproheptadine — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Cyproheptadine is approved to treat a range of allergic and related conditions across its available oral forms.
- Perennial allergic rhinitis (year-round nasal allergies) and seasonal allergic rhinitis (hay fever)
- Vasomotor rhinitis (non-allergic nasal congestion and runny nose)
- Allergic conjunctivitis caused by airborne allergens or foods (itchy, red, watery eyes)
- Urticaria (hives) and angioedema (swelling under the skin) — mild, uncomplicated cases
- Cold urticaria (hives triggered by cold exposure)
- Dermatographism (hives that form when the skin is scratched or rubbed)
- Allergic reactions to blood or plasma transfusions
- Adjunctive (supportive) therapy after the acute phase of anaphylaxis has been controlled with epinephrine and other standard treatments
⚙️How it works▾
Cyproheptadine blocks both histamine and serotonin from binding to their receptors in the body. Histamine is the main chemical behind classic allergy symptoms — itching, sneezing, runny nose, and hives. By competing with histamine for its receptor sites, cyproheptadine helps turn those symptoms off. It also has anticholinergic effects (which reduce secretions like a runny nose) and sedative properties, which is why drowsiness is a common side effect.
💊How it's taken▾
Cyproheptadine is taken by mouth, available as a tablet and as an oral solution. It is generally given two to three times a day, and the dose is tailored to each person's age, weight, and how well they respond to treatment. The oral solution is intended primarily for children but is also suitable for adults who have difficulty swallowing tablets.
- Doses are individualized — your prescriber will set the right amount for you or your child
- Do not exceed the daily maximum your prescriber specifies; limits differ by age
- Follow your prescription label closely; if you miss a dose, ask your pharmacist for guidance rather than doubling up
🤒Side effects — in detail▾
The most common side effect is drowsiness, which is often temporary but can be significant. Other effects to be aware of include:
- Dizziness or poor coordination
- Dry mouth, nose, or throat
- Nausea, stomach upset, or constipation
- Increased appetite and weight gain
- Fatigue or headache
- Restlessness or excitability (especially in young children)
- Thickening of mucus in the airways
- Blurred vision or sensitivity to light
Serious reactions are less common but real: seek immediate medical attention for signs of liver problems (yellowing skin or eyes), blood disorders (unusual bruising or persistent infections), a fast or irregular heartbeat, difficulty urinating, hallucinations, or seizures.
⚠️Warnings & precautions▾
- Drowsiness and impaired alertness: Cyproheptadine can slow your reaction time and mental alertness. Do not drive or operate machinery until you know how it affects you.
- Children and overdose: Antihistamine overdose in infants and young children can be life-threatening — possible effects include hallucinations, seizures, and cardiac or respiratory arrest. Keep this medication safely out of reach.
- Elderly patients: Older adults are at higher risk for dizziness, sedation, and low blood pressure. This drug is contraindicated in elderly or debilitated patients.
- Sedation added by alcohol and other drugs: Combining cyproheptadine with alcohol, sleep aids, sedatives, or tranquilizers greatly amplifies drowsiness and CNS depression.
- Young children may react differently: While most people become sleepy, some young children become unusually excited or agitated instead.
🔀What it interacts with▾
Cyproheptadine can interact with several substances that affect the brain or nervous system.
- MAO inhibitors (certain antidepressants such as phenelzine or tranylcypromine): intensify and prolong the anticholinergic effects of cyproheptadine — these combinations must be avoided
- Alcohol: significantly increases drowsiness and sedation — avoid drinking while taking this medication
- CNS depressants (sleep aids, sedatives, tranquilizers, anti-anxiety medications): additive sedation that can impair your ability to function safely
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use in newborn or premature infants — risk of serious harm
- Do not use if you are breastfeeding — antihistamines pass into breast milk and are especially dangerous for newborns and premature infants
- Do not use if you have angle-closure glaucoma (a type of raised eye pressure)
- Avoid if you have a stenosing peptic ulcer (a narrowing stomach ulcer), bladder neck obstruction, symptomatic enlarged prostate, or a blockage of the gut outlet (pyloroduodenal obstruction)
- Elderly or debilitated patients should not take this medication — contraindicated due to higher risks
- Tell your doctor if you have kidney problems — the drug is cleared more slowly and may build up
- Tell your doctor about all other medicines you take, especially MAO inhibitors, sedatives, or anything that causes drowsiness
- Tell your doctor if you are allergic to cyproheptadine or chemically similar medications
🚑If you take too much▾
Taking too much cyproheptadine can cause a wide range of effects — from excessive drowsiness and confusion to dangerous overstimulation, especially in children. Signs may include dry mouth, dilated pupils, flushing, hallucinations, seizures, or difficulty breathing. If an overdose is suspected, seek emergency medical care immediately — do not attempt home treatment without medical guidance.
📡Pharmacodynamics — effects in the body▾
Cyproheptadine blocks histamine and serotonin from attaching to their receptors, which reduces allergy symptoms like itching, sneezing, hives, and watery eyes. It also has anticholinergic effects — meaning it can reduce secretions and relax smooth muscle — and produces sedation. These combined properties explain both its benefits for allergy relief and many of its side effects, such as dry mouth and drowsiness.
🔬Pharmacokinetics — how your body processes it▾
After an oral dose, cyproheptadine is processed and broken down in the body, with at least 40% of the drug's byproducts excreted through the urine. The main metabolite (breakdown product) found in urine is a compound called a quaternary ammonium glucuronide conjugate. Very little unchanged drug is found in the urine of people taking it regularly, meaning the body metabolizes it extensively. People with kidney problems (renal insufficiency) clear the drug more slowly, so it can stay in the body longer.
📦How to store it▾
Dispense in a well-closed container as defined in the USP, with a child-resistant closure (as required). Store at 20° to 25°C (68° to 77°F) To report SUSPECTED ADVERSE REACTIONS, contact Beximco Pharmaceuticals USA Inc.
📄 Written from Cyproheptadine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Cyproheptadine
72 supplements and herbal products have documented interactions with Cyproheptadine in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 3
- Moderate · 57
- Minor · 12
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Cyproheptadine — the kind of thing our pharmacy team would talk through with you at the counter.
What is cyproheptadine actually used for? ▾
Is it normal to feel really tired after taking this? ▾
Can I give this to my child? ▾
Are there any medicines or drinks I should avoid while taking this? ▾
Can I take this if I'm breastfeeding? ▾
What side effects should make me call the doctor right away? ▾
Is Cyproheptadine available over the counter? ▾
When was Cyproheptadine first available? ▾
Who makes Cyproheptadine? ▾
💬 Answers drafted from Cyproheptadine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Cyproheptadine comes
Cyproheptadine is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Cyproheptadine Hydrochloride tablets treat perennial and seasonal allergic rhinitis and vasomotor rhinitis
- Relieves allergic conjunctivitis due to inhalant allergens and foods
- Treats allergic skin reactions including urticaria and angioedema
- Used adjunctively after the acute phase of anaphylaxis has been controlled
- Cyproheptadine Hydrochloride tablets are taken by mouth, usually two to three times a day
- Dose is individualized based on age, weight, and response — follow your prescriber's guidance
- For young children where precise dosing by body weight is important, the oral syrup or solution may be more appropriate than the tablet
- Do not exceed the daily maximum dose set by your prescriber
Oral solution
How this form is used
- Treats perennial and seasonal allergic rhinitis, vasomotor rhinitis, and allergic conjunctivitis
- Relieves allergic skin reactions including urticaria (hives) and angioedema
- Used for cold urticaria and dermatographism
- Used as adjunctive therapy after acute anaphylactic reactions have been controlled
- Cyproheptadine Hydrochloride Oral Solution is intended primarily for children but is also used for adults who cannot swallow tablets
- Doses are given two to three times a day and adjusted based on age, weight, and individual response
- cyproheptadine hydrochloride solution dose should be individualized — always follow your prescriber's specific instructions
- Do not exceed the daily dose limit set by your prescriber; limits differ by age group
📊 Cyproheptadine across the U.S. market
How Cyproheptadine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (10) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Cyproheptadine is used
A general measure of how commonly Cyproheptadine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Cyproheptadine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Cyproheptadine prescribed? Of the 1,596 medications we measure, Cyproheptadine ranks #193 by Medicaid prescriptions — more than 88% of them.
Utilization by Cyproheptadine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
cyproheptadine hydrochloride 4 MG Oral Tablet Most dispensed
Summed across the 13 of 100 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 866144
cyproheptadine hydrochloride 0.4 MG/ML Oral Solution
Summed across the 6 of 16 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 866021
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Cyproheptadine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 19 of 116 listed Cyproheptadine NDCs with Medicaid activity.
🔍 Compare Cyproheptadine products
A representative set of FDA-listed product records for Cyproheptadine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Oral solution | ||||
| 2 mg/5 mL | Oral | Atlantic Biological Corp. | ANDA | View NDC → |
| 2 mg/5 mL | Oral | Atlantic Biologicals Corp. × 2 listings | ANDA | View NDC → |
| 2 mg/5 mL | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 2 mg/5 mL | Oral | Chartwell RX, LLC × 2 listings | ANDA | View NDC → |
| 2 mg/5 mL | Oral | Lannett Company, Inc. | ANDA | View NDC → |
| 2 mg/5 mL | Oral | Method Pharmaceuticals, LLC | ANDA | View NDC → |
| 2 mg/5 mL | Oral | Patrin Pharma, Inc. | ANDA | View NDC → |
| 2 mg/5 mL | Oral | Quagen Pharmaceuticals Llc × 4 listings | ANDA | View NDC → |
| 2 mg/5 mL | Oral | Rising Pharmaceuticals, Inc. | ANDA | View NDC → |
| 2 mg/5 mL | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 2 mg/5 mL | Oral | Tris Pharma Inc | ANDA | View NDC → |
| 2 mg/5 mL | Oral | VistaPharm, Inc. | ANDA | View NDC → |
| 2 mg/5 mL | Oral | VistaPharm, LLC | ANDA | View NDC → |
| 💊Tablet | ||||
| 4 mg | Oral | A-S Medication Solutions × 5 listings | ANDA | View NDC → |
| 4 mg | Oral | Amneal Pharmaceuticals of New York LLC × 4 listings | ANDA | View NDC → |
| 4 mg | Oral | Apnar Pharma | ANDA | View NDC → |
| 4 mg | Oral | AvKARE | ANDA | View NDC → |
| 4 mg | Oral | AvPAK × 3 listings | ANDA | View NDC → |
| 4 mg | Oral | Bayshore Pharmaceuticals LLC | ANDA | View NDC → |
| 4 mg | Oral | Breckenridge Pharmaceutical, Inc. | ANDA | View NDC → |
| 4 mg | Oral | Bryant Ranch Prepack × 12 listings | ANDA | View NDC → |
| 4 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 4 mg | Oral | Golden State Medical Supply × 2 listings | ANDA | View NDC → |
| 4 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 4 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 4 mg | Oral | Ingenus Pharmaceuticals LLC × 2 listings | ANDA | View NDC → |
| 4 mg | Oral | Marlex Pharmaceuticals Inc | ANDA | View NDC → |
| 4 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 4 mg | Oral | Proficient Rx LP × 2 listings | ANDA | View NDC → |
| 4 mg | Oral | QPharma Inc × 3 listings | ANDA | View NDC → |
| 4 mg | Oral | Quagen Pharmaceuticals Llc | ANDA | View NDC → |
| 4 mg | Oral | Quality Care Products, LLC | ANDA | Find on DailyMed ↗ |
| 4 mg | Oral | Remedyrepack Inc. × 6 listings | ANDA | View NDC → |
| 4 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 4 mg | Oral | Strides Pharma Science Limited × 2 listings | ANDA | View NDC → |
| 4 mg | Oral | Trupharma, Llc × 3 listings | ANDA | View NDC → |
| 4 mg | Oral | Unichem Pharmaceuticals (usa), Inc. | ANDA | View NDC → |
| 4 mg | Oral | Westminster Pharmaceuticals, LLC | ANDA | View NDC → |
| 4 mg | Oral | Zydus Lifesciences Limited × 2 listings | ANDA | View NDC → |
| 4 mg | Oral | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Dipharma Francis Srl | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Letco Medical, Llc | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 g/g | — | Medisca Inc. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Olon S.p.A. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Olon SpA | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | R.L.Fine Chem Private Limited | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Spectrum Laboratory Products, Inc. | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Vamsi Labs Limited. | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Vasudha Pharma Chem Limited × 2 listings | BULK INGREDIENT | View NDC → |
Showing 92 of 92 products — FDA National Drug Code Directory. See every product, package size and price: browse all 92 Cyproheptadine NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Cyproheptadine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Cyproheptadine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Cyproheptadine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 3013 2 dose forms · 2 strengths
-
Dose form (SCDF) Oral Solution RxCUI 702213In current FDA listingsClinical drug / strength (SCD) hydrochloride 0.4 MG/MLRxCUI 866021 -
Dose form (SCDF) Oral Tablet RxCUI 371670In current FDA listingsClinical drug / strength (SCD) hydrochloride 4 MGRxCUI 866144
Look up RxCUI 3013 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Cyproheptadine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 36 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Chartwell RX, LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.